5-羟色胺转运蛋白基因多态性与抑郁症发病及抗抑郁治疗关系的研究进展

被引:8
作者
武力勇 [1 ]
魏镜 [2 ]
李舜伟 [2 ]
机构
[1] 首都医科大学宣武医院神经内科
[2] 北京协和医院神经内科
关键词
抑郁症; 基因多态性; HTT; 忧郁症; 情感性精神病; 遗传多态性; 单相抑郁; SSRI; 帕罗西汀; 抑郁症患者; 吲哚; 色胺;
D O I
暂无
中图分类号
R749.4 [情感性精神病];
学科分类号
100205 ;
摘要
引用
收藏
页码:244 / 246
页数:3
相关论文
共 5 条
[1]   5-羟色胺转运蛋白基因多态性与抗抑郁药临床疗效的关系 [J].
肖红 ;
姚辉 ;
郭苏婉 ;
李箕君 ;
吴如金 .
中国临床药学杂志, 2003, (04) :204-207
[2]   Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment [J].
Albert Putzhammer ;
Anja Schoeler ;
Thomas Rohrmeier ;
Philipp Sand ;
Goeran Hajak ;
Peter Eichhammer .
Psychopharmacology, 2005, 178 :303-308
[3]  
Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. Zanardi R,Benedetti F,Di Bella D,et al. Journal of Clinical Psychopharmacology . 2000
[4]  
Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Yoshida K, Ito K, Sato K, et al. Progress in Neuropsychopharmacology and Biological Psychiatry . 2002
[5]  
Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment. Lee MS,Lee HY,Lee HJ,et al. Psychiatric Genetics . 2004